Although there are key players in multiple geographies worldwide, Japan has positioned itself as a hub for induced pluripotent stem cell (iPS cell) technology. iPS cells are made by reprogramming adult cells back into an embryonic-like state. Derived from skin or blood cells, they are not controversial.
Since the discovery of induced pluripotent stem cells (iPSCs) in 2006, a large and thriving research products market has emerged, largely because the cells are non-controversial and can be generated directly from adult cells. It is clear that iPSCs represent a lucrative market segment, because methods for commercializing this cell type are expanding every year and clinical studies investigating iPSCs are swelling in number. [Read more…]
Since the discovery of induced pluripotent stem cell (iPSC) technology 15 years ago, significant progress has been made in stem cell biology and regenerative medicine. New pathological mechanisms have been identified, new drugs identified by iPSC screens are in the pipeline, and the first clinical trials employing human iPSC-derived cell types have been initiated.
As we enter 2021, Cynata Therapeutics is initiating a historic trial that will utilize its iPSC-derived product, CYP-004, in 440 patients with osteoarthritis (OA). This will be the world’s first Phase 3 trial to administer an iPSC-derived cellular therapeutic to human patients and the largest one ever. [Read more…]
Most people are interested in healthy aging, longevity and a long life span. These pursuits are intrinsic to optimizing the human experience.
In our quest for tools and technologies to support this aim, the scientific community has begun exploring the connection between stem cells and aging. Study after study is coming out delineating the paramount importance of stem cells in the aging process.
If you are into anti-aging research, stem cell therapy, and the intersection of these fields of research, then let’s dive in. [Read more…]
Induced pluripotent stem cells (iPS cells) can be made by reprogramming mature adult cells back into an embryonic-like state. Derived from skin or blood cells, iPS cells are not controversial, because they are made from adult cells. As pluripotent stem cells, they can give rise to all of the tissues that form the human body. [Read more…]